Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder?
Vikky Morris,1 Adrian Wagg21Geriatric Medicine, Taunton Hospital Somerset, UK; 2Division of Geriatric Medicine, University of Alberta, Edmonton, Alberta, CanadaAbstract: Overactive bladder (OAB), a clinically defined symptom complex comprising urinary urgency, usually accompanied by urinary frequenc...
Saved in:
Main Authors: | Morris V (Author), Wagg A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fesoterodine for the treatment of urinary incontinence and overactive bladder
by: Pamela Ellsworth
Published: (2009) -
The experience of using fesoterodine in patients with overactive bladder in the older age group
by: Elena I. Ermakova
Published: (2020) -
Mirabegron in the Management of Overactive Bladder Syndrome
by: O'Kane M, et al.
Published: (2022) -
Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain
by: Peral C, et al.
Published: (2016) -
Overactive bladder
by: Anna Zwierzyńska
Published: (2021)